Literature DB >> 15628249

The number of malignant neoplasm in Sarajevo region during the period 1998-2002.

Nermina Obralić1, Faris Gavrankapetanović, Zehra Dizdarević, Osman Durić, Fuad Sisić, Ivan Selak, Snjezana Balta, Bakir Nakas.   

Abstract

UNLABELLED: Due to the specific war and post-war situation in Bosnia and Herzegovina it is possible to notice some differences in the number, type, advancement, biological course, treatment and its outcome. The actual situation which appeared in connection to depleted uranium has additionally raised questions about its influence on human health and about eventual increase in the number of malignant diseases in Bosnia and Herzegovina. In public, we often see that there are claims about enormous increase in the incidence of cancer. In order to achieve a realistic picture of actual condition and to avoid panic and ignorant attitude, correct and constant data of malignant tumors are necessary. THE AIM OF THE STUDY: To collect and analyze data on population with malignant tumors in the region of Sarajevo city, which represents a symbol of difficult times in our country in the recent past.
MATERIAL AND METHODS: We have collected and analysed data on, population with malignant tumors which included persons with permanent residence in Sarajevo Canton during 5-year period, from 01.01.1998, until 31.12.2002. Results were compared to regional and world indicators, and were observed in the light of specific local situation.
RESULTS: During period of 5 years (1998-2002) 7733 new cases of malignant tumors were registered in Sarajevo Canton; 3940 among men and 3809 among women. Mostly registered tumors were: lung cancer, amelanotic skin tumors, breast cancer, colorectal cancer, cervical and uterine cancer, urinary bladder cancer, prostate cancer and cancer of larynx.
CONCLUSIONS: Number of all malignant tumors in the region of Sarajevo Canton correlates to those in South European countries and the one estimated by GLOBCAN 2000. High number was registered in 1998, possibly due to normalization of the health services (diagnostics and treatment of malignant tumors), which didn't exist during the war and early post-war period. After 2000, there is a gradual increase in the number of people with malignant tumors. The most common tumors are lung and breast cancer. Significant differences to estimation and data registrated in other South European counties is high number of laryngeal cancer, urinary bladder cancer, bone and cartilage sarcoma, brain tumors and malignant lymphomas among both genders. Cervical cancer is extremely high up on the list, which correlates with data in developing countries. The incidence of smoking in Bosnia and Herzegovina is extremely high, almost complete, which can influence not only the appearance of lung cancer but also laryngeal and urinary bladder cancer. It is hard to say whether the war and post-war stress, irregular and insufficient nutrition during and after the siege of the city or some other factor have influenced their appearance among exposed population and differences in the observed incidence.

Entities:  

Mesh:

Year:  2004        PMID: 15628249

Source DB:  PubMed          Journal:  Med Arh        ISSN: 0350-199X


  4 in total

1.  Effect of war and postwar genotoxins on micronuclei frequency in Sarajevo study group.

Authors:  Slavka Ibrulj; Sanin Haverić; Anja Haverić; Adaleta Durmić-Pasić; Damir Marjanović
Journal:  Bosn J Basic Med Sci       Date:  2006-11       Impact factor: 3.363

2.  Chromosome aberrations as bioindicators of environmental genotoxicity.

Authors:  Slavica Ibrulj; Sanin Haverić; Anja Haverić
Journal:  Bosn J Basic Med Sci       Date:  2007-11       Impact factor: 3.363

Review 3.  The toxicity of depleted uranium.

Authors:  Wayne Briner
Journal:  Int J Environ Res Public Health       Date:  2010-01-25       Impact factor: 3.390

Review 4.  The evolution of depleted uranium as an environmental risk factor: lessons from other metals.

Authors:  Wayne E Briner
Journal:  Int J Environ Res Public Health       Date:  2006-06       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.